Replies to post #70863 on Ocata Therapeutics Inc fka OCAT

[macnqueso]

"Frankly, we don't need more data than this."

That is a pretty small sample size... if only you were the FDA...

[lasers]

rumper excellent postings ! Not only was this a miracle rescue of vision from 20/400 to 20/40, there is also NOT ONE case of adversity in +3 years with +35 RPE patients.

Yes indeed we are all dumfounded as to what in God's name is the FDA waiting for. The FDA should be Commercially approving a BLA for $ACTC's RPE AMD and SMD treatments. All +35 patients want their second eye injected with $ACTC's RPEs. As well untreated patients are now a mile long wanting their eyes injected with $ACTC's RPEs!